Speakers

Lior Raviv

Chief Technical Officer • Pluri

Lior Raviv joined Pluristem in 2011 and currently serves as Chief Technology Officer. Prior to that Mr. Raviv served as Projects manager & Product development Team leader at Pluristem in charge of new technologies and process development. Prior to joining Pluristem and during the years 2010-2011, Mr Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries. Mr. Raviv holds a M.Med.Sec in pharmacology from the Ben Gurion University and a B.S.c, in Biotechnology engineering from the Ben Gurion University.

Also Speaking

Jennifer Collins

Principal, Apheresis and Infusion Specialist • Vertex Cell and Gene Therapies

Tony Ward

Chief Technology Officer • Curate Biosciences

Scott Bertch

Executive Director, Clinical Site Head • Tenaya Therapeutics

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.